Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Burden of neurological conditions in Canada.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Dimethyl fumarate protection against collagen II degradation.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Glatiramer acetate induced hepatotoxicity.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Evidence for Mitoxantrone-induced Block of Inwardly Rectifying K Channels Expressed in the Osteoclast Precursor RAW 264.7 Cells Differentiated with Lipopolysaccharide.
Rare onset symptoms in multiple sclerosis.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
Voiding Dysfunction in Multiple Sclerosis.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Pages
« first
‹ previous
…
77
78
79
80
81
82
83
84
85
…
next ›
last »